As of 2025-07-04, the Relative Valuation of Evelo Biosciences Inc (EVLO) is (36,792.51) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.32 USD, the upside of Evelo Biosciences Inc based on Relative Valuation is -11624907.1%.
The range of the Relative Valuation is (28,170.98) - (51,125.12) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 18.6x | 13.1x |
| Forward P/E multiples | 10.3x - 21.2x | 13.7x |
| Fair Price | (28,170.98) - (51,125.12) | (36,792.51) |
| Upside | -8900885.1% - -16153376.7% | -11624907.1% |
| Date | P/E |
| 2025-07-02 | -0.00 |
| 2025-06-17 | -0.00 |
| 2025-06-16 | -0.00 |
| 2025-06-09 | -0.00 |
| 2025-06-04 | -0.00 |
| 2025-06-02 | -0.00 |
| 2025-05-23 | -0.00 |
| 2025-05-21 | -0.00 |
| 2025-05-19 | -0.00 |
| 2025-05-13 | -0.00 |
| 2025-05-12 | -0.00 |
| 2025-05-02 | -0.00 |
| 2025-04-29 | -0.00 |
| 2025-04-28 | -0.00 |
| 2025-04-25 | -0.00 |
| 2025-04-24 | -0.00 |
| 2025-04-23 | -0.00 |
| 2025-04-22 | -0.00 |
| 2025-04-21 | -0.00 |
| 2025-04-16 | -0.00 |
| 2025-04-09 | -0.00 |
| 2025-04-08 | -0.00 |